CRL Charles River Laboratories International Inc.

Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call

Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call
EN
13/10/2020

Underlying

CRLCharles River Laboratories International Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Charles River Laboratories International Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 42.80
PII POLARIS INC.
PBF PBF Energy Inc... ... (+30)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

PII POLARIS INC.
PBF PBF ENERGY INC. CLASS A
LEN LENNAR CORPORATION CLASS A
GPRE GREEN PLAINS INC.
GBCI GLACIER BANCORP INC.
FFIC FLUSHING FINANCIAL CORP.
DVN DEVON ENERGY CORPORATION
DECK DECKERS OUTDOOR CORPORATION
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CNO CNO FINANCIAL GROUP INC.
CBU COMMUNITY BANK SYSTEM INC.
BIIB BIOGEN INC.
BC BRUNSWICK CORPORATION
HP HELMERICH & PAYNE INC.
PVH PVH CORP.
TTC TORO COMPANY
HOG HARLEY-DAVIDSON INC.
WGO WINNEBAGO INDUSTRIES INC.
APLS APELLIS PHARMACEUTICALS
PRPL PURPLE INNOVATION
GRWG GROWGENERATION
DCOM DIME COMMUNITY BANCSHARES INC
APA APA CORPORATION
AMR ALPHA METALLURGICAL RESOURCES INC
BBWI BATH & BODY WORKS INC
CIVI CIVITAS RESOURCES INC
BORR BORR DRILLING LTD
MBC_w MASTERBRAND INC
NE NOBLE CORP (NEW)
FTREV FORTREA HOLDINGS INC.
08/28/25 August 28, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 42.80
WEX WEX INC.
ALLE ALLEGION PLC ... (+23)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

WEX WEX INC.
ALLE ALLEGION PLC
TMUS T-MOBILE US INC.
TRU TRANSUNION
ROL ROLLINS INC.
MXL MAXLINEAR INC
LVS LAS VEGAS SANDS CORP.
ICLR ICON PLC
FCN FTI CONSULTING INC.
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CHDN CHURCHILL DOWNS INCORPORATED
MEDP MEDPACE HOLDINGS INC.
KFRC KFORCE INC.
RELL RICHARDSON ELECTRONICS LTD.
ADT ADT INC
KOD KODIAK SCIENCES
FTREV FORTREA HOLDINGS INC.
OUST OUSTER INC
CTNM CONTINEUM THERAPEUTICS INC
UPB UPSTREAM BIO INC
UMAC UNUSUAL MACHS INC NEV
MIMI MINT INCORPORATION LTD
ALMU AELUMA INC
07/25/25 July 25, 2025 1 EN
CRL Charles River L...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Charles River Laboratories Int'l, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 March 2025 in which we reassessed the appropriateness of the rati...

CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
03/19/25 March 19, 2025 1 EN
 PRESS RELEASE
Free
CRL Charles River L...

Charles River Laboratories to Present at Barclays Global Healthcare Co...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12th, at 9:30 a.m. ET. Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at . A webcast replay will be accessible through the same website after the presentation and will rem...

March 11, 2025 1 EN
 PRESS RELEASE
Free
CRL Charles River L...

Charles River Announces Agreement with Singapore General Hospital

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement with Singapore General Hospital (SGH) to provide Current Good Manufacturing Practice (CGMP) -compliant master cell banking (MCB) and next-generation sequencing (NGS)-based services for use in cell line characterization. SGH will use cord blood to derive and manufacture allogeneic chimeric antigen receptor (CAR) T-cells which will be used to treat patients with cancer. “We are thrilled to leverage our cell line characterization services and comprehensive NGS testing app...

February 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch